Sign In / Register
Make This My Home Page | Feedback |RSS
You are here: IE »   Story

HIV/AIDS: 2nd line of treatment too costly, no Govt policy yet

  • Print
  • Mail This Article
  • Comments
  • Add to favorites
  • Though the Government has provided medicines for about 96,000 patients as against 47,000 under treatment with the National AIDS Control Organisation (NACO), these are only the basic first line of medication.

    Under the Government’s policy the new improved drugs are not available in Government hospitals and patients who have developed resistance to the first line of treatment have to buy them on their own. “Our main effort is to provide the basic treatment for millions of HIV positive people. The second line of treatment is very expensive and we cannot afford to provide it free at this point,’’ said Sujatha Rao, director-general NACO.

    Before changing the treatment protocol, NACO is planning a drug resistance study in four centres. The study to be conducted by NARI (PUNE), Tuberculosis Research Centre, Chennai, NICD Kolkata and AIIMS in Delhi is likely to be started early next year.

    Ads by Google

    Previous12
    Comments
    Post comment

    Be the first to comment.

    Post a Comment
    Name:
    Email:
    Title:
    Maximum characters allowed     
    Comment:
    TERMS OF USE:
    The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
    I agree to the terms of use.